Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Step by step instructions to Guarantee Your Internet Promoting Degree Supplements Your Profession Objectives - 2Hundreds rally in West Bank against Israeli death penalty for Palestinians
- 3Figure out How to Streamline Eco-friendliness in Your Volvo XC40
- 4Jeff Bezos’ Blue Origin launches landmark Mars mission in New Glenn rocket’s first big test
- 5HGV driver recruited others to smuggle migrants
- Sustaining Public activity and Connections: Key Methodologies
- The most effective method to Offset Album Rates with Liquidity Needs
- Journey through Pages: A Survey of \Plunging into Scholarly Universes\
- 6 Travel Services for Colorful Get-aways: Pick Your Fantasy Escape
- The Tiny Channel Island With 65 Residents That Chefs And Foodies Go Out Of Their Way To Visit
- Investigate These Retreats Well known With Seniors
- Turkey key underlying issue as Israel, Greece, Cyprus hold summit
- Iranian strikes on Israel injure 11 and set chemical plant ablaze
- Track down the Ideal Weight reduction Methodology for Your Way of life
